Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07210606) titled 'Central Apnea in Heart Failure: Physiological Mechanisms to Inform Treatment' on Sept. 29.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: VA Office of Research and Development
Condition:
Sleep Disordered Breathing
Able Bodied
Intervention:
Drug: Trazodone + PAP therapy
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: January 1, 2026
Target Sample Size: 200
Countries of Recruitment:
United States
To know more, visit https:/...